Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02594254 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2 study of Dental Caries, sponsored by Armata Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 135
- Enrollment target
- 10
- Study locations
NCT02594254 is a Phase 2 study of Dental Caries that has completed, run by Armata Pharmaceuticals. The registered enrollment target is 135 participants, below the 718-participant average among 30 other Dental Caries trials with a reported enrollment target (81% lower). The trial reports 10 study locations across 8 states.
The verdict
NCT02594254, a Phase 2 study of Dental Caries, has completed, sponsored by Armata Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 135 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this study is to evaluate if C16G2 Gel administered over a certain period of time either with a toothbrush or a custom dental tray can effectively kill bacteria in the mouth that cause dental cavities.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG C16G2 Gel
Study Locations (10)
Montana
- John F. Pittaway, DMD - Kalispell
- Plaza West II Dental Group - Kalispell
Texas
- Texas Baylor College of Dentistry - Dallas
- Anthony Henegar, DDS, PA - Irving
California
- Imperial Beach Family Dentistry - Imperial Beach
Indiana
- Indiana University School of Dentistry - Indianapolis
Massachusetts
- Tufts University - Boston
New York
- New York University College of Dentistry - New York
North Carolina
- East Carolina University - Greenville
Pennsylvania
- University of Pennsylvania School of Dental Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02594254
The ClinicalTrials.gov registry entry for NCT02594254 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 718-participant average among 30 other Dental Caries trials with a reported enrollment target (81% lower). The listed sponsor is Armata Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02594254 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Montana, Texas, California.
Frequently Asked Questions
What is clinical trial NCT02594254 about?
NCT02594254 is a clinical study titled "Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects". The purpose of this study is to evaluate if C16G2 Gel administered over a certain period of time either with a toothbrush or a custom dental tray can effectively kill bacteria in the mouth that cause dental cavities.
What is the current status of trial NCT02594254?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 135 participants. The study started on 2015-11. Estimated completion is 2016-09.
What conditions does trial NCT02594254 study?
This clinical trial studies the following conditions: Dental Caries.
What interventions are being tested in trial NCT02594254?
The interventions under investigation include: Placebo (OTHER), C16G2 Gel (DRUG).
Who is sponsoring clinical trial NCT02594254?
This trial is sponsored by Armata Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02594254 being conducted?
This trial has 10 study locations across California, Indiana, Massachusetts, Montana, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Caries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children
COMPLETED · Phase 2
-
Comparing Stainless Steel Crowns with Prefabricated Resin Crowns in Primary Molar Teeth
RECRUITING · NA
-
LT Comparative Effectiveness of 2 Caries Treatments
RECRUITING · NA
-
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
RECRUITING · NA
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
Polymer Induced Liquid Precursor (PILP) in Adults in With Dentin Caries
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.